Mikhail Kalinichev
Geneve, GE 1202, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Negative allosteric modulator of the metabotropic glutamate receptor 7 ADX71743 increases wakefulness, reduces sleep, and alters stress-induced changes in the brain neurotransmitter levels.
Journal: The international journal of neuropsychopharmacology
Published: January 08, 2026
The effect of recombinant botulinum neurotoxin A on neuropathic pain in the spared nerve injury mouse model.
Journal: Journal of neural transmission (Vienna, Austria : 1996)
Published: February 03, 2025
Intradermally injected abobotulinumtoxinA administered preemptively before surgery alleviates post-surgical pain and normalizes behavior in a translational animal model.
Journal: Scientific reports
Published: May 22, 2024
The safety of botulinum neurotoxin type A's intraarticular application in experimental animals.
Journal: Toxicon: X
Published: February 16, 2023
Effect of the Metabotropic Glutamate Receptor Type 5 Negative Allosteric Modulator Dipraglurant on Motor and Non-Motor Symptoms of Parkinson's Disease.
Journal: Cells
Published: February 15, 2023
Intraoperative abobotulinumtoxinA alleviates pain after surgery and improves general wellness in a translational animal model.
Journal: Scientific reports
Published: April 03, 2022
Evaluation of Recombinant Botulinum Neurotoxin Type A1 Efficacy in Peripheral Inflammatory Pain in Mice.
Journal: Frontiers in molecular neuroscience
Published: March 31, 2022
Glycine receptor subunit-β-deficiency in a mouse model of spasticity results in attenuated physical performance, growth, and muscle strength.
Journal: American journal of physiology. Regulatory, integrative and comparative physiology
Published: February 02, 2022
Recombinant botulinum neurotoxin serotype A1 in vivo characterization.
Journal: Pharmacology research & perspectives
Published: January 11, 2021
Last Updated: 09/26/2026